-transparent.png){kind=logo}
The effect of somatostatin on the secretion of calcitonin was studied in four patients with medullary carcinoma of the thyroid (MCT). The basal serum calcitonin level was markedly elevated in all cases. A bolus injection (100 microgram) of somatostatin followed by an intravenous infusion (5 microgram/min) for 60 min suppressed the basal calcitonin level in three of the four patients by 24-42%, while it had no inhibitory effect in one case. In another experiment, the pentagastrin-stimulated (6 microgram/kg s.c.) calcitonin release was partially blocked by a simultaneous i.v. injection of somatostatin (200 microgram) in all four patients studied. These experiments add human calcitonin to the list of hormones whose release in inhibited by somatostatin.
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
May 1975,
Lancet (London, England),
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
January 1980,
Acta radiologica. Oncology,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
January 1985,
Archivos de investigacion medica,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
December 2006,
World journal of surgical oncology,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
June 1981,
Regulatory peptides,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
April 1983,
Cancer,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
November 1973,
Lancet (London, England),
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
May 1984,
Metabolism: clinical and experimental,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
March 2013,
Langenbeck's archives of surgery,
A Gordin, and
B A Lamberg, and
R Pelkonen, and
S Almqvist
April 1972,
Archives of surgery (Chicago, Ill. : 1960),
